A multicenter phase II study of docetaxel (D) and carboplatin (CBDCA) combination in advanced non-small cell lung cancer (NSCLC). A preliminary analysis.

被引：0
|
作者：
Giannakakis, T [1 ]
Kakolyris, S [1 ]
Papadouris, S [1 ]
Mavroudis, D [1 ]
Kalbakis, K [1 ]
Souglakos, J [1 ]
Agelaki, S [1 ]
Passam, F [1 ]
Mixaki, J [1 ]
Georgoulias, V [1 ]
机构：
[1] Greek Cooperat Grp Lung Canc, Heraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
547P
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [21] Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
    W. Schuette
    I. Bork
    B. Wollschläger
    S. Schädlich
    Clinical Drug Investigation, 2001, 21 : 161 - 168
  • [22] Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer
    Schuette, W
    Bork, I
    Wollschläger, B
    Schädlich, S
    CLINICAL DRUG INVESTIGATION, 2001, 21 (03) : 161 - 168
  • [23] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in locally advanced non-small cell lung cancer (NSCLC)
    Aerts, Joachim G.
    van Klaveren, Rob J.
    Surmont, Veerle
    Senan, Suresh
    Tan, Yoeke
    Vernhout, Rene
    van Wijhe, Gerda
    Verhoeven, Gert T.
    Hoogsteden, Henk C.
    van Meerbeeck, Jan P.
    ANNALS OF ONCOLOGY, 2004, 15 : 174 - 175
  • [24] A phase II and pharmacogenomic study of Irinotecan and carboplatin in advanced non-small cell lung cancer (NSCLC).
    Pillot, GA
    Hennenfent, K
    Read, W
    Marsh, S
    McLeod, HL
    Gao, F
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
  • [25] A multicenter phase II study of sorafenib in combination with erlotinib patients with advanced non-small cell lung cancer (NSCLC)
    Cho, B.
    Kim, S.
    Heo, D. S.
    Kang, S.
    Kim, H.
    Lee, D.
    Kim, D.
    Jung, M.
    Choi, J.
    Kim, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1076 - 1076
  • [27] Retrospective analysis of administration of a combination of docetaxel and carboplatin for advanced non-small cell lung cancer
    Bando, H
    Miyata, J
    Sano, T
    Sumitomo, M
    ANTICANCER RESEARCH, 2001, 21 (3C) : 2107 - 2113
  • [28] Preliminary report of a phase II study of docetaxel (taxotere(R) and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Douillard, JY
    Monnier, A
    Ibrahim, N
    Belli, L
    Sun, XS
    Soulas, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1096 - 1096
  • [29] A phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer
    Zarogoulidis, K
    Kontakiotis, T
    Hatziapostolou, P
    Fachantidou, E
    Delis, D
    Goutsikas, J
    Constantinidis, TC
    Athanasiadis, A
    Patakas, D
    LUNG CANCER, 2001, 32 (03) : 281 - 287
  • [30] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    LUNG CANCER, 2005, 49 : S242 - S242
12345